1 / 33

Atropisomerism in biaryl-containing natural products

Department of Chemistry, University of Wisconsin-Madison. Atropisomerism in biaryl-containing natural products. Joseph P. Gerdt Blackwell Group 12 November, 2009. Chirality is important!. CHALLENGING. indistinguishable in achiral environment. (S)-carvone. (R)-thalidomide.

jaron
Télécharger la présentation

Atropisomerism in biaryl-containing natural products

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Department of Chemistry, University of Wisconsin-Madison Atropisomerism in biaryl-containing natural products Joseph P. Gerdt Blackwell Group 12 November, 2009

  2. Chirality is important! CHALLENGING indistinguishable in achiral environment (S)-carvone (R)-thalidomide (S)-thalidomide (R)-carvone teratogen spearmint dill, caraway sleep aid, antiemetic INTERESTING IMPORTANT but, Nature is a chiral environment

  3. Atropisomers are axially chiral chirality depends on ΔGrot, temperature, and timescale ΔGrot= 29.9 kcal/mol t1/2 (25°C) = 30 years ΔGrot= 18.5 kcal/mol t1/2 (25°C) = 4 sec aR or M ΔGrot= 17.7 kcal/mol t1/2 (25°C) = 1 sec aS or P G Bringmann et al. (2001) Prog. Chem Org. Nat. Prod.82:1-249. C Wolf (2008) Dynamic Stereochemistry of Chiral Compounds:Principles and Applications.

  4. Natural products exhibit atropisomerism R = disaccharide gossypol anticancer naphthylisoquinolines antimalarials vancomycin antibiotic atroposelective coupling: equilibration: dynamic kinetic resolution:

  5. Gossypol toxic yellow pigment from cotton plants (aS)-(−)-gossypol (aR)-(+)-gossypol in Nature: ranges from 30% ee (−) to 90% ee (+) G Bringmann et al. (2001) Prog. Chem Org. Nat. Prod.82:1-249. J. Qiu et al. (2002) Exp. Biol. Med. 227:398-401; J Wei et al. (2009) Cancer Letters 273:107-113.

  6. Gossypol biosynthesis hemigossypol (aS)-(−)-gossypol guided by dirigent proteins J Liu et al. (2008) Phytochemistry69: 3038-3042. SC Halls et al. (2004) Biochemistry 43:2587-2595.

  7. Gossypol chemical synthesis atroposelective Ullmann coupling: AI Meyers, JJ Willemsen (1998) Tetrahedron54:10493-10511. TD Nelson, AI Meyers (1994) J. Org. Chem.59:2655-2658.

  8. Gossypol chemical synthesis 8% total yield AI Meyers, JJ Willemsen (1998) Tetrahedron54:10493-10511. TD Nelson, AI Meyers (1994) J. Org. Chem.59:2655-2658.

  9. Gossypol summary Nature: guided by dirigent proteins vs. Meyers: guided by oxazolines

  10. Vancomycin -forms 5 H-bonds with D-ala-D-ala peptidoglycan terminus -prevents cross-linking N-acyl-D-ala-D-ala embedded in cell membrane BK Hubbard, CT Walsh (2003) ACIEE 42:730-765. PJ Loll et al. (1998) Chem. Biol.5:293-298; image: wrap.warwick.ac.uk.

  11. Vancomycin aglycon biosynthesis aS -chain built by non-ribosomal peptide synthetase (NRPS) BK Hubbard, CT Walsh (2003) ACIEE 42:730-765.

  12. NRPS and oxidative coupling peptide carrier protein NRPS termination module: Iron-heme oxidative coupling enzymes (OxyB, OxyA, OxyC) NRPS assembly line (3rd) OxyC OxyB (1st) OxyA (2nd) PF Widboom, SD Bruner (2009) ChemBioChem 10:1757-1764. K Woithe et al. (2007) JACS 129:6887-6895

  13. Evans vancomycin aglycon synthesis DA Evans et al. (1998) ACIEE37:2700-2704 DA Evans et al. (1993) JACS115:6426-6527; DA Evans, CJ Dinsmore (1993) Tet. Lett. 34:6029-6032.

  14. Evans vancomycin aglycon synthesis unnatural isomer DA Evans et al. (1998) ACIEE37:2700-2704 DA Evans et al. (1993) JACS115:6426-6527; DA Evans, CJ Dinsmore (1993) Tet. Lett. 34:6029-6032.

  15. Evans vancomycin aglycon synthesis 0.7% total yield DA Evans et al. (1998) ACIEE37:2700-2704 DA Evans et al. (1993) JACS115:6426-6527; DA Evans, CJ Dinsmore (1993) Tet. Lett. 34:6029-6032.

  16. Vancomycin summary atroposelective coupling equilibration KC Nicolaou et al. (1999) ACIEE38:2096-2152.

  17. Naphthylisoquinoline alkaloids -plant self defense -antimalarials 5 6’ 3’ 7 8’ 1’ naphthyl tetrahydroisoquinoline korupensamines A & B (5,8’) dioncopeltine A (7,1’) dioncophylline B (7,6’) config. unstable dioncophylline C (5,1’) VERY ACTIVE antimalarial G Bringmann et al. (2001) Prog. Chem Org. Nat. Prod.82:1-249. image: Rotislav Simek, bestcarnivorousplants.com

  18. Bringmann lactone method asymmetric lactone opening (dynamic kinetic resolution) (config. unstable) Dioncopeltine A synthesis: (config. unstable) dioncopeltine A 27% yield G Bringmann et al. (2005) ACIEE44:5384-5427. G Bringmann et al. (1999) Tetrahedron55:423-432.

  19. Bringmann lactone method korupensamine A korupensamine A 3% yield G Bringmann et al. (2005) ACIEE44:5384-5427. G Bringmann et al. (2000) J. Org. Chem.65:2069-2077.

  20. Atroposelective Suzuki reaction atropisomer not isolated 5-epi-4’-O-demethylancistrobertsonine C IC50 vs. P. falciparum = 0.11 ug/ml 0.27 ug/ml unnatural natural 1 2 (Rc,Sp)-11 (Sc,Rp)-11 G Bringmann et al. (2008) Tetrahedron64:5563-5568. G Bringmann et al. (2008) Phytochemistry69:1065-1075.

  21. Naphthylisoquinoline summary asymmetric lactone opening (dynamic kinetic resolution) (config. unstable)

  22. Conclusions -atropisomerism is an exciting “twist” on chirality -many important biaryl natural products exist as configurationally stable atropisomers -several interesting atroposelective synthetic methods exist

  23. New challenge (−)-marinopyrrole A ancistrocladinium A C-N bound configurationally stable biaryls: CC Hughes et al. (2008) Org. Lett.10:629-631. G Bringmann et al. (2006) J. Org. Chem.71:9348-9356. images: Ahmed et al. (2008) Internet J. Microbiol.4(2); Kamarudin Mat-Sellah

  24. Acknowledgments Prof. Helen Blackwell Blackwell Group: Dr. Andrew Palmer Margie Mattmann Joey Stringer RetoFrei Christie McInnis Tony Breitbach Aaron Crapster Knick Praneenararat Danielle Stacy Teresa Beary Amanda Senechal Additional practice talk attendees: Olga Dykho Joe Grim Anna Hurtley Shane Mangold Brad Ryland Liz Tyson Ryan Weber Adam Weinstein Kevin Williamson

  25. Nicolaou vancomycin aglycon synthesis -Used stereoselective Suzuki coupling to set biaryl stereochemistry dr: 3.5:1 75% yield dr: >95:5 40% yield dr: 2:1 74% yield KC Nicolaou et al. (1999) Chem. Eur. J.5:2584-2601. KC Nicolaou et al. (1998) ACIEE37:2708-2714; KC Nicolaou et al. (1999) ACIEE38:2096-2152.

  26. Stobbe condensation??? G Bringmann et al. (2005) ACIEE44:5384-5427. G Bringmann et al. (2000) J. Org. Chem.65:2069-2077.

  27. Evans vancomycin aglycon synthesis -Used nearby stereochemistry to thermodynamically favor the desired aS AB stereochemistry. A B C DA Evans et al. (1998) ACIEE37:2700-2704, DA Evans et al. (1997) JACS119:3417-3418. DA Evans et al. (1993) JACS115:6426-6527; DA Evans, CJ Dinsmore (1993) Tet. Lett. 34:6029-6032.

  28. Summary – synthetic methods I. Atroposelective coupling: controlled by chiral auxiliaries, ligands, or the substrate itself Gossypol, 17:1 dr 5-epi-4’-O-demethyl-ancistroobertsonine, 66:34 dr (fix ligand)

  29. Summary – synthetic methods Need for atroposelective syntheses to find SARs, novel therapeutics. II. Thermal equilibration: controlled by chiral auxiliaries or the substrate itself III. Dynamic kinetic resolution: atroposelective opening of configurationally unstable lactone vancomycin, >95:5 dr dioncopeltine A, >95:5 dr

  30. Evans vancomycin aglycon synthesis Why pref aS?, double check structures, remove DG A B C Why pref aS?, double check structures, remove DG—mention earlier?-KEEP FOR BACKUP! K not =1!!! So t1/2 from favored to unfavored is 240 hr, maybe!!! b/c that forward rate is slower!!! So, maybe 150 secs x 100 = 15000 secs, 5 hrs. Just change dG, too??? (MODELS) Once remove that unnatural Obenzyl (used to activate ring for ox coupling), The stereocenters in the three aa’s favor 10:1 natural aS axial stereochemistry Then, even furthermore, when add 4th aa and cyclize the COD ring, increase thermodynamic preference to 50:1/100:1! Recall…in biosynthesis, it is believed that the last step is this biaryl linkage, so quite possible that the vancomycin molecule itself, has a large effect in directing the coupling. ALSO, one more thing to address from this study—did kinetics of biaryl bond rotation—only ones I have seen w/ vanco AB ring, closest to real thing, the only AB-fused 3 AA showed Ea 20.8 kcal/mol, t1/2 23* 29 hr AB-, COD-fused 4 AA model showed Ea21.5 kcal/mol, t/12 23*C 230 hr (~10 days)—so config stable, but not great. BUT, consider where this molecule is found and acts. In soil quite possibly near 23*C. OK, probably config stable for extent of time the cell needs it. BUT, in human treatment, 37*C  150 secs!!!!??? (double check calc!) DA Evans et al. (1998) ACIEE37:2700-2704, DA Evans et al. (1997) JACS119:3417-3418. DA Evans et al. (1993) JACS115:6426-6527; DA Evans, CJ Dinsmore (1993) Tet. Lett. 34:6029-6032.

  31. Evans vancomycin aglycon synthesis (remove aS,cisoid) increase width of sterics K not =1!!! So t1/2 from favored to unfavored is 240 hr, maybe!!! b/c that forward rate is slower!!! So, maybe 150 secs x 100 = 15000 secs, 5 hrs. Just change dG, too??? (MODELS) Once remove that unnatural Obenzyl (used to activate ring for ox coupling), The stereocenters in the three aa’s favor 10:1 natural aS axial stereochemistry Then, even furthermore, when add 4th aa and cyclize the COD ring, increase thermodynamic preference to 50:1/100:1! Recall…in biosynthesis, it is believed that the last step is this biaryl linkage, so quite possible that the vancomycin molecule itself, has a large effect in directing the coupling. ALSO, one more thing to address from this study—did kinetics of biaryl bond rotation—only ones I have seen w/ vanco AB ring, closest to real thing, the only AB-fused 3 AA showed Ea 20.8 kcal/mol, t1/2 23* 29 hr AB-, COD-fused 4 AA model showed Ea21.5 kcal/mol, t/12 23*C 230 hr (~10 days)—so config stable, but not great. BUT, consider where this molecule is found and acts. In soil quite possibly near 23*C. OK, probably config stable for extent of time the cell needs it. BUT, in human treatment, 37*C  150 secs!!!!??? (double check calc!) <5:95 89:11 >98:2 aR:aS - DA Evans et al. (1998) ACIEE37:2700-2704, DA Evans et al. (1997) JACS119:3417-3418. DA Evans et al. (1993) JACS115:6426-6527; DA Evans, CJ Dinsmore (1993) Tet. Lett. 34:6029-6032.

  32. Gossypol summary Nature: guided by dirigent proteins More practical deracemization: vs. Meyers: guided by oxazolines

  33. Bringmann lactone method asymmetric lactone opening (dynamic kinetic resolution) (config. unstable) Dioncopeltine A synthesis: (config. unstable) What if X = H? dioncopeltine A 27% yield G Bringmann et al. (2005) ACIEE44:5384-5427. G Bringmann et al. (1999) Tetrahedron55:423-432.

More Related